Cohen Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Cohen Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827K	Hold	14,350	–	–	0.11%	98
2026 Q1	$870K	Hold	14,350	–	–	0.14%	94
2025 Q4	$774K	Hold	14,350	–	–	0.12%	102
2025 Q3	$647K	Hold	14,350	–	–	0.1%	106
2025 Q2	$664K	Hold	14,350	–	–	0.11%	107
2025 Q1	$875K	Hold	14,350	–	–	0.15%	89
2024 Q4	$812K	Hold	14,350	–	–	0.14%	95
2024 Q3	$742K	Hold	14,350	–	–	0.12%	101
2024 Q2	$596K	Sell	14,350 -40	-0.3%	-$1.79K	0.1%	108
2024 Q1	$780K	Hold	14,390	–	–	0.14%	94
2023 Q4	$738K	Hold	14,390	–	–	0.14%	93
2023 Q3	$835K	Hold	14,390	–	–	0.17%	92
2023 Q2	$920K	Hold	14,390	–	–	0.18%	88
2023 Q1	$997K	Hold	14,390	–	–	0.2%	87
2022 Q4	$1.04M	Hold	14,390	–	–	0.21%	88
2022 Q3	$1.02M	Hold	14,390	–	–	0.23%	86
2022 Q2	$1.11M	Hold	14,390	–	–	0.23%	90
2022 Q1	$1.05M	Buy	14,390 +40	+0.3%	+$2.69K	0.18%	94
2021 Q4	$895K	Hold	14,350	–	–	0.15%	97
2021 Q3	$849K	Hold	14,350	–	–	0.15%	101
2021 Q2	$959K	Hold	14,350	–	–	0.16%	98
2021 Q1	$906K	Sell	14,350 -40	-0.3%	-$2.49K	0.17%	96
2020 Q4	$893K	Sell	14,390 -650	-4%	-$40K	0.18%	94
2020 Q3	$907K	Hold	15,040	–	–	0.2%	93
2020 Q2	$884K	Hold	15,040	–	–	0.22%	92
2020 Q1	$838K	Hold	15,040	–	–	0.25%	79
2019 Q4	$965K	Buy	15,040 +40	+0.3%	+$2.29K	0.21%	87
2019 Q3	$761K	Hold	15,000	–	–	0.17%	94
2019 Q2	$680K	Hold	15,000	–	–	0.16%	95
2019 Q1	$716K	Hold	15,000	–	–	0.17%	93
2018 Q4	$780K	Hold	15,000	–	–	0.22%	86
2018 Q3	$931K	Hold	15,000	–	–	0.21%	92
2018 Q2	$830K	Hold	15,000	–	–	0.19%	96
2018 Q1	$790K	Hold	15,000	–	–	0.19%	91
2017 Q4	$919K	Hold	15,000	–	–	0.21%	84
2017 Q3	$956K	Hold	15,000	–	–	0.23%	82
2017 Q2	$836K	Hold	15,000	–	–	0.21%	83
2017 Q1	$816K	Hold	15,000	–	–	0.21%	82
2016 Q4	$877K	Hold	15,000	–	–	0.24%	76
2016 Q3	$809K	Hold	15,000	–	–	0.23%	78
2016 Q2	$1.1M	Hold	15,000	–	–	0.32%	68
2016 Q1	$1.03M	Hold	15,000	–	–	0.31%	70
2015 Q4	$1.03M	Hold	15,000	–	–	0.31%	70
2015 Q3	$888K	Hold	15,000	–	–	0.27%	76
2015 Q2	$998K	Hold	15,000	–	–	0.26%	81
2015 Q1	$967K	Hold	15,000	–	–	0.25%	81
2014 Q4	$885K	Hold	15,000	–	–	0.23%	82
2014 Q3	$768K	Hold	15,000	–	–	0.2%	84
2014 Q2	$728K	Sell	15,000 -3,195	-18%	-$157K	0.19%	86
2014 Q1	$945K	Buy	18,195 +3,195	+21%	+$170K	0.25%	78
2013 Q4	$797K	Hold	15,000	–	–	0.22%	81
2013 Q3	$694K	Hold	15,000	–	–	0.21%	83
2013 Q2	$670K	Buy	+15,000	New	+$651K	0.21%	83

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Cohen Capital Management's BMY Position: Q2 2026 in Review

Cohen Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 14,350 shares worth $827K. The position accounts for 0.11% of the portfolio, ranked #98.

Cohen Capital Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.11M in Q2 2022. 945 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cohen Capital Management held 14,350 shares of Bristol-Myers Squibb worth $827K as of Q2 2026.
Cohen Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.11% of Cohen Capital Management's portfolio in Q2 2026, its #98 holding.
Cohen Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Cohen Capital Management's Bristol-Myers Squibb position peaked at $1.11M in Q2 2022.
945 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cohen Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.